相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of Castration-Resistant Prostate Cancer: Updates on Therapeutics Targeting the Androgen Receptor Signaling Pathway
Wenhui Zhu et al.
AMERICAN JOURNAL OF THERAPEUTICS (2010)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells
Chih-Pin Chuu et al.
CANCER LETTERS (2009)
Tea Polyphenols Decrease Serum Levels of Prostate-Specific Antigen, Hepatocyte Growth Factor, and Vascular Endothelial Growth Factor in Prostate Cancer Patients and Inhibit Production of Hepatocyte Growth Factor and Vascular Endothelial Growth Factor In vitro
Jerry McLarty et al.
CANCER PREVENTION RESEARCH (2009)
miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
Judit Ribas et al.
CANCER RESEARCH (2009)
MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation
K-H Lee et al.
ONCOGENE (2009)
A Novel Dietary Flavonoid Fisetin Inhibits Androgen Receptor Signaling and Tumor Growth in Athymic Nude Mice
Naghma Khan et al.
CANCER RESEARCH (2008)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Genomic profiling of MicroRNA and messenger RNA reveals deregulated MicroRNA expression in prostate cancer
Stefan Ambs et al.
CANCER RESEARCH (2008)
Targeting the androgen receptor pathway in prostate cancer
Yu Chen et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling
Margaret M. Centenera et al.
MOLECULAR ENDOCRINOLOGY (2008)
Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells
M. Asim et al.
ONCOGENE (2008)
Suppression of NF kappa B and its Regulated Gene Products by Oral Administration of Green Tea Polyphenols in an Autochthonous Mouse Prostate Cancer Model
Imtiaz A. Siddiqui et al.
PHARMACEUTICAL RESEARCH (2008)
Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis
I. A. Siddiqui et al.
ONCOGENE (2008)
Widespread deregulation of microRNA expression in human prostate cancer
M. Ozen et al.
ONCOGENE (2008)
Structural characterization of the human androgen receptor ligand-binding domain complexed with EM5744, a rationally designed steroidal ligand bearing a bulky chain directed toward helix 12
Line Cantin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
MicroRNA expression profiling in prostate cancer
Kati P. Porkka et al.
CANCER RESEARCH (2007)
Epigallocatechin-3-gallate and bicalutamide cause growth arrest and apoptosis in NRP-152 and NRP-154 prostate epithelial cells
Colm Morrissey et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Combined inhibitory effects of green tea polyphenols and selective cyclooxygenase-2 inhibitors on the growth of human prostate cancer cells both in vitro and in vivo
Vaqar Mustafa Adhami et al.
CLINICAL CANCER RESEARCH (2007)
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
Renee Chmelar et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
The androgen receptor T877A mutant recruits LXXLL and FXXLF peptides differently than wild-type androgen receptor in a time-resolved fluorescence resonance energy transfer assay
Mary Szatkowski Ozers et al.
BIOCHEMISTRY (2007)
Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer
Emma C. Stuart et al.
LIFE SCIENCES (2006)
Inhibition of CWR22Rν1 tumor growth and PSA secretion in athymic nude mice by green and black teas
IA Siddiqui et al.
CARCINOGENESIS (2006)
Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study
S Bettuzzi et al.
CANCER RESEARCH (2006)
Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells
P Hååg et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2005)
c-Myc-regulated microRNAs modulate E2F1 expression
KA O'Donnell et al.
NATURE (2005)
Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease
C Ricciardelli et al.
PROSTATE (2005)
Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer
XB Liao et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth
CL Hsu et al.
MOLECULAR ENDOCRINOLOGY (2005)
Mutation of the androgen receptor causes oncogenic transformation of the prostate
GZ Han et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells
K Brusselmans et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Interactions of androgens, green tea catechins and the antiandrogen flutamide with the external glucose-binding site of the human erythrocyte glucose transporter GLUT1
RJ Naftalin et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control
HK Weir et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Expression and degradation of androgen receptor: Mechanism and clinical implication
DK Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Role of p53 and NF-κB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells
K Hastak et al.
ONCOGENE (2003)
Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer
ER Hyytinen et al.
LABORATORY INVESTIGATION (2002)
Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor
D Masiello et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells
FG Ren et al.
ONCOGENE (2000)
Growth inhibition, cell-cycle dysregulation, and induction of apoptosis by green tea constituent (-)-epigallocatechin-3-gallate in androgen-sensitive and androgen-insensitive human prostate carcinoma cells
S Gupta et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2000)
分享论文
